Search Results for: "genentech v samsung bioepis bevacizumab"

BPCIA Litigations

Pending U.S. District Court BPCIA Litigations Litigation Accused Biosimilar [status] Reference Product Complaint Filed Status/Outcome District Court Appeal Genentech v. Samsung Bioepis, No. 20-859 (D. Del.) SB8 (bevacizumab biosimilar) [not approved] AVASTIN [litigation #3] June 28, 2020 Pending Resolved U.S. District Court BPCIA Litigations # Litigation Accused Biosimilar [status] Reference…

Read More